Could high ALT indicate liver damage?

Elevated ALT levels often signal liver cell damage, with normal ranges typically 7-56 U/L for men and 7-45 U/L for women. While high ALT can indicate conditions from fatty liver disease to hepatitis, it requires additional testing and clinical context for accurate diagnosis.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What is ALT and Why Does It Matter?

Alanine aminotransferase (ALT) is an enzyme found primarily in liver cells that plays a crucial role in amino acid metabolism. When liver cells are damaged or inflamed, ALT leaks into the bloodstream, making it one of the most sensitive markers for liver health. Healthcare providers routinely check ALT levels as part of comprehensive metabolic panels or liver function tests to screen for potential liver problems before symptoms appear.

ALT serves as an early warning system for liver health. Unlike many liver conditions that remain silent until advanced stages, elevated ALT can detect problems when they're still reversible. This enzyme is particularly abundant in hepatocytes (liver cells), which is why even minor liver cell damage can cause noticeable increases in blood ALT levels.

Understanding ALT Reference Ranges

Normal ALT levels vary slightly between laboratories and populations, but generally fall within these ranges:

ALT Level Categories and Clinical Significance

ALT levels should be interpreted in context with other liver tests and clinical findings.
ALT LevelCategoryPotential CausesRecommended Action
Normal<30 U/L (men), <20 U/L (women)OptimalHealthy liverContinue healthy lifestyle
Borderline30-56 U/L (men), 20-45 U/L (women)Upper normalEarly NAFLD, medicationsLifestyle modifications, recheck in 3-6 months
Mild elevation1.5-3x upper limitMildNAFLD, medications, viral hepatitisFurther testing, identify cause
Moderate elevation3-10x upper limitModerateActive hepatitis, alcohol, autoimmuneComprehensive evaluation needed
Severe elevation>10x upper limitSevereAcute liver injury, drug toxicityUrgent medical evaluation

ALT levels should be interpreted in context with other liver tests and clinical findings.

  • Men: 7-56 units per liter (U/L)
  • Women: 7-45 units per liter (U/L)
  • Children: May have slightly higher normal ranges

However, optimal ALT levels may be lower than these standard reference ranges. Some research suggests that ALT levels above 30 U/L in men and 20 U/L in women may indicate early metabolic dysfunction, even if they fall within the "normal" range. Understanding your baseline ALT and tracking changes over time provides more valuable information than a single measurement.

Factors Affecting ALT Levels

Several factors can influence ALT levels beyond liver health. Body mass index (BMI) correlates with ALT, as individuals with obesity often have higher baseline levels. Exercise can temporarily elevate ALT, particularly after intense strength training. Certain medications, including statins, antibiotics, and acetaminophen, may also raise ALT levels. Additionally, ALT can fluctuate throughout the day and vary with dietary patterns.

Common Causes of Elevated ALT

Non-Alcoholic Fatty Liver Disease (NAFLD)

NAFLD represents the most common cause of elevated ALT in developed countries, affecting approximately 25% of the global population. This condition occurs when excess fat accumulates in liver cells without significant alcohol consumption. Risk factors include obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. ALT levels in NAFLD typically range from mildly elevated (1.5-2 times normal) to moderately elevated (2-5 times normal).

Viral Hepatitis

Hepatitis B and C viruses cause chronic liver inflammation that manifests as persistently elevated ALT. Acute hepatitis infections can cause dramatic ALT elevations, sometimes exceeding 1000 U/L. Chronic viral hepatitis typically presents with more modest elevations, often fluctuating between normal and 2-5 times the upper limit of normal. Early detection through ALT monitoring enables timely antiviral treatment that can prevent progression to cirrhosis.

While AST (aspartate aminotransferase) typically rises more than ALT in alcohol-related liver disease, ALT elevations still occur. The pattern of enzyme elevation helps distinguish alcoholic from non-alcoholic liver disease. Chronic alcohol consumption causes progressive liver damage, from fatty liver to alcoholic hepatitis and eventually cirrhosis. Even moderate alcohol intake can elevate ALT in susceptible individuals.

Symptoms Associated with High ALT

Elevated ALT itself doesn't cause symptoms, but the underlying liver conditions responsible for the elevation may produce various signs and symptoms. Many people with mildly elevated ALT experience no symptoms at all, which is why routine blood testing is crucial for early detection.

When symptoms do occur, they may include:

  • Fatigue and weakness
  • Right upper abdominal discomfort or pain
  • Nausea and loss of appetite
  • Unexplained weight loss
  • Jaundice (yellowing of skin and eyes) in advanced cases
  • Dark urine and pale stools
  • Itchy skin
  • Swelling in legs and abdomen

The severity and combination of symptoms often correlate with the degree of liver damage and the underlying cause. Acute liver injury typically presents with more dramatic symptoms, while chronic liver disease may progress silently for years.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Approach to Elevated ALT

When ALT levels are elevated, healthcare providers follow a systematic approach to determine the cause. The first step involves confirming the elevation with repeat testing, as transient elevations can occur. If persistently elevated, additional liver enzymes (AST, alkaline phosphatase, GGT) and bilirubin help characterize the pattern of liver injury.

Further testing may include:

  • Viral hepatitis serologies (Hepatitis B and C)
  • Autoimmune markers (ANA, ASMA, anti-LKM)
  • Metabolic tests (ferritin, ceruloplasmin, alpha-1 antitrypsin)
  • Imaging studies (ultrasound, CT, or MRI)
  • Liver biopsy in selected cases

The pattern of enzyme elevation provides diagnostic clues. An ALT/AST ratio greater than 1 suggests non-alcoholic fatty liver disease or viral hepatitis, while a ratio less than 1 (with AST predominance) indicates alcoholic liver disease or cirrhosis. Regular monitoring through comprehensive metabolic panels helps track liver health over time and assess response to treatment.

Treatment and Management Strategies

Lifestyle Modifications

For many causes of elevated ALT, particularly NAFLD, lifestyle changes form the cornerstone of treatment. Weight loss of 5-10% can significantly reduce liver fat and normalize ALT levels. A Mediterranean-style diet rich in vegetables, fruits, whole grains, and healthy fats shows particular benefit for liver health. Regular aerobic exercise and resistance training both improve insulin sensitivity and reduce liver fat, even without significant weight loss.

Medical Interventions

Treatment depends on the underlying cause of ALT elevation. Viral hepatitis may require antiviral medications, while autoimmune hepatitis needs immunosuppressive therapy. For NAFLD, medications targeting insulin resistance, such as pioglitazone or GLP-1 agonists, may help. Vitamin E supplementation (800 IU daily) has shown benefit in non-diabetic adults with NASH (non-alcoholic steatohepatitis). Always work with healthcare providers to develop an appropriate treatment plan based on your specific condition.

Monitoring Progress

Regular ALT monitoring helps assess treatment effectiveness and disease progression. Most experts recommend checking ALT levels every 3-6 months initially, then adjusting frequency based on response to treatment. Normalization of ALT often indicates improvement in liver inflammation, though some patients with advanced fibrosis may have normal ALT levels. Combining ALT trends with other markers and imaging provides a comprehensive view of liver health.

Prevention and Long-Term Outlook

Preventing ALT elevation focuses on maintaining overall metabolic health. This includes maintaining a healthy weight, following a balanced diet low in processed foods and added sugars, exercising regularly, limiting alcohol consumption, and avoiding unnecessary medications or supplements that can stress the liver. Vaccination against hepatitis A and B provides protection against these viral causes of liver disease.

The prognosis for elevated ALT depends entirely on the underlying cause and how quickly it's addressed. Many conditions causing elevated ALT, particularly NAFLD and medication-induced liver injury, are reversible with appropriate intervention. Even chronic conditions like viral hepatitis now have highly effective treatments. Early detection through regular monitoring allows for timely intervention before irreversible liver damage occurs.

Understanding your liver health through biomarkers like ALT empowers you to take proactive steps toward prevention and early intervention. Regular testing, combined with a healthy lifestyle and appropriate medical care when needed, helps ensure optimal liver function throughout life. Remember that ALT is just one piece of the puzzle – comprehensive metabolic testing provides the full picture of your liver and overall health status.

References

  1. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35.[PubMed][DOI]
  2. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.[PubMed][DOI]
  3. Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology. 2012;55(2):447-454.[PubMed][DOI]
  4. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357.[PubMed][DOI]
  5. Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6-19.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ALT at home?

You can test your ALT at home with SiPhox Health's Heart & Metabolic Program, which includes ALT testing along with other liver enzymes like AST. This CLIA-certified program provides lab-quality results from the comfort of your home with personalized insights about your liver health.

What is the normal range for ALT?

Normal ALT ranges are typically 7-56 U/L for men and 7-45 U/L for women, though optimal levels may be lower (under 30 U/L for men and 20 U/L for women). These ranges can vary slightly between laboratories.

Can ALT levels return to normal?

Yes, ALT levels can often return to normal with appropriate treatment of the underlying cause. Lifestyle changes like weight loss, dietary improvements, and avoiding alcohol can normalize ALT in many cases of fatty liver disease.

How often should I test my ALT levels?

If you have elevated ALT, most experts recommend testing every 3-6 months initially to monitor trends and treatment response. Once levels normalize, annual testing may be sufficient unless you have ongoing liver conditions.

What's the difference between ALT and AST?

Both are liver enzymes, but ALT is more specific to the liver while AST is found in multiple organs. The ALT/AST ratio helps identify the cause of liver damage - ratios >1 suggest NAFLD or viral hepatitis, while <1 may indicate alcoholic liver disease.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details